Home > Insider Trading > Filing (0001079973-20-000006)

Filing Details

Accession Number:: 0001079973-20-000006
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-07 17:11:31
Reporting Period:: 2019-12-19

Accepted Time:: 2020-01-07 17:11:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1128189	Protokinetix Inc.	PKTX	Pharmaceutical Preparations (2834)	943355026

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516077	Edward Clarence Smith	1845 County Road #214 St. Augustine FL 32084	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-19	216,666	$0.12	54,899,999	No	4	P	Direct
Common Stock	Acquisiton	2019-12-30	21,551	$0.10	13,185,711	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-12-31	45,249	$0.11	13,230,960	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-01-03	4,200	$0.10	13,235,160	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2019-12-19	216,666	$0.00	216,666	$0.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
216,666	2019-12-19	2022-12-18	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,850,000	Indirect	See footnote

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$0.11	2024-11-17	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.26	2024-07-14	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.26	2024-07-14	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.09	2023-11-08	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.06	2021-08-31	5,000,000	5,000,000	Direct
Common Stock	Stock Option	$0.05	2020-12-31	5,000,000	5,000,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-11-17	5,000,000	5,000,000	Direct
2024-07-14	5,000,000	5,000,000	Direct
2024-07-14	5,000,000	5,000,000	Direct
2023-11-08	5,000,000	5,000,000	Direct
2021-08-31	5,000,000	5,000,000	Direct
2020-12-31	5,000,000	5,000,000	Direct

Footnotes

Acquired pursuant to private placement. This Form 4 corrects the prior Form 4 which incorrectly reported a total of 61,353,833 shares held by Mr. Smith personally. Based on a review of stockholder reports, the corrected number of shares is 54,683,333 before the transactions reported herein.
Shares held by the Clarence E. Smith Trusts. This Form 4 corrects the prior Form 4 which incorrectly reported a total of 6,467,883 held in trust. Based on a review of brokerage statements and stockholder lists, the corrected total number of shares held by the trusts before the transactions reported herein is 13,164,160.
This transaction was executed in multiple trades at prices ranging from $0.1 to $0.11. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held by Mr. Smith's retirement account.
Acquired pursuant to private placement.
Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on November 18, 2019. 1,250,000 shares of common stock vest on February 18, 2020; thereafter 1,250,000 shares vest every three months until fully vested on November 18, 2020.
Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on July 15, 2019. 1,250,000 shares of common stock vest on October 13, 2019; thereafter 1,250,000 shares vest every three months until fully vested on July 13, 2020.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.